國家級人體生物資料庫整合平台共同資料模式實作指引(NBCT Common Data Model IG)
0.1.0 - trial-use

Publication Build: This will be filled in by the publication tooling

## : SSF1 白血病-白血病染色體檢查的評估代碼系統 - XML Representation

Active as of 2024-08-01

Raw xml | Download

    <CodeSystem xmlns="http://hl7.org/fhir">
      <id value="ssf-1-leukemia-codesystem"/>
      <text>
        <status value="generated"/>
        <div xmlns="http://www.w3.org/1999/xhtml"><p class="res-header-id"><b>Generated Narrative: CodeSystem ssf-1-leukemia-codesystem</b></p><a name="ssf-1-leukemia-codesystem"> </a><a name="hcssf-1-leukemia-codesystem"> </a><a name="ssf-1-leukemia-codesystem-en-US"> </a><p>This case-sensitive code system <code>https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/ssf-1-leukemia-codesystem</code> defines the following codes:</p><table class="codes"><tr><td style="white-space:nowrap"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style="white-space:nowrap">000<a name="ssf-1-leukemia-codesystem-000"> </a></td><td>正常</td></tr><tr><td style="white-space:nowrap">001<a name="ssf-1-leukemia-codesystem-001"> </a></td><td>AML with t(8;21)(q22;q22.1</td></tr><tr><td style="white-space:nowrap">002<a name="ssf-1-leukemia-codesystem-002"> </a></td><td>AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)</td></tr><tr><td style="white-space:nowrap">003<a name="ssf-1-leukemia-codesystem-003"> </a></td><td>Acute promyelocytic leukemia with t(15;17)</td></tr><tr><td style="white-space:nowrap">004<a name="ssf-1-leukemia-codesystem-004"> </a></td><td>AML with t(9;11)(p21.3;q23.3)</td></tr><tr><td style="white-space:nowrap">005<a name="ssf-1-leukemia-codesystem-005"> </a></td><td>AML with t(6;9)(p23;q34.1)</td></tr><tr><td style="white-space:nowrap">006<a name="ssf-1-leukemia-codesystem-006"> </a></td><td>AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)</td></tr><tr><td style="white-space:nowrap">007<a name="ssf-1-leukemia-codesystem-007"> </a></td><td>AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)</td></tr><tr><td style="white-space:nowrap">013<a name="ssf-1-leukemia-codesystem-013"> </a></td><td>AML with t(9;22)(q34;q11)</td></tr><tr><td style="white-space:nowrap">021<a name="ssf-1-leukemia-codesystem-021"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)</td></tr><tr><td style="white-space:nowrap">022<a name="ssf-1-leukemia-codesystem-022"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(v;11q23.3)</td></tr><tr><td style="white-space:nowrap">023<a name="ssf-1-leukemia-codesystem-023"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)</td></tr><tr><td style="white-space:nowrap">024<a name="ssf-1-leukemia-codesystem-024"> </a></td><td>B lymphoblastic leukemia / lymphoma with hyperdiploidy</td></tr><tr><td style="white-space:nowrap">025<a name="ssf-1-leukemia-codesystem-025"> </a></td><td>B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)</td></tr><tr><td style="white-space:nowrap">026<a name="ssf-1-leukemia-codesystem-026"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)</td></tr><tr><td style="white-space:nowrap">027<a name="ssf-1-leukemia-codesystem-027"> </a></td><td>B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)</td></tr><tr><td style="white-space:nowrap">041<a name="ssf-1-leukemia-codesystem-041"> </a></td><td>Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)</td></tr><tr><td style="white-space:nowrap">042<a name="ssf-1-leukemia-codesystem-042"> </a></td><td>Mixed phenotype acute leukemia with t(v;11q23.3)</td></tr><tr><td style="white-space:nowrap">051<a name="ssf-1-leukemia-codesystem-051"> </a></td><td>Chronic myelogenous leukemia，t(9;22)</td></tr><tr><td style="white-space:nowrap">061<a name="ssf-1-leukemia-codesystem-061"> </a></td><td>Myelodysplastic syndrome associated with isolated del(5q-)</td></tr><tr><td style="white-space:nowrap">090<a name="ssf-1-leukemia-codesystem-090"> </a></td><td>(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常</td></tr><tr><td style="white-space:nowrap">091<a name="ssf-1-leukemia-codesystem-091"> </a></td><td>同時有兩種上述之染色體異常</td></tr><tr><td style="white-space:nowrap">092<a name="ssf-1-leukemia-codesystem-092"> </a></td><td>複雜之染色體異常，指三項(含)以上的染色體變化者</td></tr><tr><td style="white-space:nowrap">8XX<a name="ssf-1-leukemia-codesystem-8XX"> </a></td><td>Chromosome study after chemotherapy or immunotherapy or target therapy</td></tr><tr><td style="white-space:nowrap">988<a name="ssf-1-leukemia-codesystem-988"> </a></td><td>不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)</td></tr><tr><td style="white-space:nowrap">998<a name="ssf-1-leukemia-codesystem-998"> </a></td><td>有執行染色體檢查，但結果無法判斷</td></tr><tr><td style="white-space:nowrap">999<a name="ssf-1-leukemia-codesystem-999"> </a></td><td>病歷未記載或不詳或未執行染色體檢查</td></tr></table></div>
      </text>
      <url
           value="https://www.ghd.tw/cdm-fhir/fhir/CodeSystem/ssf-1-leukemia-codesystem"/>
      <version value="0.1.0"/>
      <name value="SSF1leukemiaCS"/>
      <title value="SSF1 白血病-白血病染色體檢查的評估代碼系統"/>
      <status value="active"/>
      <experimental value="false"/>
      <date value="2024-08-01T15:33:47+08:00"/>
      <publisher value="國家級人體生物資料庫整合平台"/>
      <contact>
        <telecom>
          <system value="url"/>
          <value value="https://ghd.tw/"/>
        </telecom>
      </contact>
      <description
                   value="Assessment of chromosome study in leukemia Code System"/>
      <caseSensitive value="true"/>
      <content value="complete"/>
      <count value="27"/>
      <concept>
        <code value="000"/>
        <display value="正常"/>
      </concept>
      <concept>
        <code value="001"/>
        <display value="AML with t(8;21)(q22;q22.1"/>
      </concept>
      <concept>
        <code value="002"/>
        <display value="AML with inv(16)(p13.1q22) or t(16;16)(p13.1;q22)"/>
      </concept>
      <concept>
        <code value="003"/>
        <display value="Acute promyelocytic leukemia with t(15;17)"/>
      </concept>
      <concept>
        <code value="004"/>
        <display value="AML with t(9;11)(p21.3;q23.3)"/>
      </concept>
      <concept>
        <code value="005"/>
        <display value="AML with t(6;9)(p23;q34.1)"/>
      </concept>
      <concept>
        <code value="006"/>
        <display value="AML with inv(3)(q21.3q26.2) or t(3;3)(q21.3;q26.2)"/>
      </concept>
      <concept>
        <code value="007"/>
        <display value="AML (megakaryoblastic) with t(1;22)(p13.3;q13.1)"/>
      </concept>
      <concept>
        <code value="013"/>
        <display value="AML with t(9;22)(q34;q11)"/>
      </concept>
      <concept>
        <code value="021"/>
        <display
                 value="B lymphoblastic leukemia / lymphoma with t(9;22)(q34.1;q11.2)"/>
      </concept>
      <concept>
        <code value="022"/>
        <display value="B lymphoblastic leukemia / lymphoma with t(v;11q23.3)"/>
      </concept>
      <concept>
        <code value="023"/>
        <display
                 value="B lymphoblastic leukemia / lymphoma with t(12;21)(p13.2;q22.1)"/>
      </concept>
      <concept>
        <code value="024"/>
        <display value="B lymphoblastic leukemia / lymphoma with hyperdiploidy"/>
      </concept>
      <concept>
        <code value="025"/>
        <display
                 value="B lymphoblastic leukemia / lymphoma with hypodiploidy (hypodiploid ALL)"/>
      </concept>
      <concept>
        <code value="026"/>
        <display
                 value="B lymphoblastic leukemia / lymphoma with t(5;14)(q31.1;q32.1)"/>
      </concept>
      <concept>
        <code value="027"/>
        <display
                 value="B lymphoblastic leukemia / lymphoma with t(1;19)(q23;p13.3)"/>
      </concept>
      <concept>
        <code value="041"/>
        <display
                 value="Mixed phenotype acute leukemia with t(9;22)(q34.1;q11.2)"/>
      </concept>
      <concept>
        <code value="042"/>
        <display value="Mixed phenotype acute leukemia with t(v;11q23.3)"/>
      </concept>
      <concept>
        <code value="051"/>
        <display value="Chronic myelogenous leukemia，t(9;22)"/>
      </concept>
      <concept>
        <code value="061"/>
        <display
                 value="Myelodysplastic syndrome associated with isolated del(5q-)"/>
      </concept>
      <concept>
        <code value="090"/>
        <display
                 value="(1) 一種異常，其他上述未列之染色體異常 (2) 二種異常，其中一種非上述之染色體異常 (3) 二種異常，二種皆非上述之染色體異常"/>
      </concept>
      <concept>
        <code value="091"/>
        <display value="同時有兩種上述之染色體異常"/>
      </concept>
      <concept>
        <code value="092"/>
        <display value="複雜之染色體異常，指三項(含)以上的染色體變化者"/>
      </concept>
      <concept>
        <code value="8XX"/>
        <display
                 value="Chromosome study after chemotherapy or immunotherapy or target therapy"/>
      </concept>
      <concept>
        <code value="988"/>
        <display value="不適用。(1) ICD-O-3 M-9811-9837 (EXCEPT C42.0, 42.1, 42.4)"/>
      </concept>
      <concept>
        <code value="998"/>
        <display value="有執行染色體檢查，但結果無法判斷"/>
      </concept>
      <concept>
        <code value="999"/>
        <display value="病歷未記載或不詳或未執行染色體檢查"/>
      </concept>
    </CodeSystem>